Search

Agilent Technologies Inc

Closed

SectorHealthcare

149.77 -1.02

Overview

Share price change

24h

Current

Min

147.29

Max

152.66

Key metrics

By Trading Economics

Income

23M

362M

Sales

43M

1.9B

P/E

Sector Avg

30.228

56.659

EPS

1.62

Dividend yield

0.66

Profit margin

19.276

Employees

18,000

EBITDA

-27M

473M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.39% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.66%

2.18%

Next Earnings

23 lis 2026

Next Dividend date

21 paź 2026

Next Ex Dividend date

29 wrz 2026

Market Stats

By TradingEconomics

Market Cap

-35M

43B

Previous open

150.79

Previous close

149.77

News Sentiment

By Acuity

74%

26%

305 / 340 Ranking in Healthcare

Agilent Technologies Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2026, 20:08 UTC

Agilent Technologies Inc is advancing today, supported by a positive trend in the Life Sciences Tools & Services sub-sector amid overall market gains since Tuesday.

1 wrz 2026, 20:03 UTC

News

Agilent Technologies launched the Cary 635 FTIR spectrometer, but shares are trading lower today amid persistent weakness in the stock's performance.

31 sie 2026, 19:16 UTC

News
Correlated Moves

Agilent Technologies reported fiscal Q3 revenue of $1.88 billion. Shares are lower today, following broader market trends despite raised price targets from analysts.

28 sie 2026, 20:02 UTC

News

Agilent Technologies shares decline despite raised fiscal 2026 revenue guidance and strong Q3 results, amid broader market pressure from rising U.S. Treasury yields.

27 sie 2026, 20:02 UTC

News

Analysts raised price targets for Agilent Technologies, reflecting increased confidence. Citigroup, Stifel, RBC Capital, and Bernstein reaffirmed Buy ratings amid positive sentiment.

26 sie 2026, 23:02 UTC

News

Agilent Technologies reported Q3 revenue of $1.88 billion, exceeding estimates. Shares are trading higher in after-market hours following the raised full-year guidance.

25 sie 2026, 23:16 UTC

Agilent Technologies Inc shares rose in after-market trading, supported by a decline in crude oil prices and broader positive market sentiment.

24 sie 2026, 23:21 UTC

Agilent Technologies Inc shares are lower in after-market hours, with no specific news identified for the decline. The broader market also reflects weakness.

21 sie 2026, 23:56 UTC

Agilent Technologies Inc shares are lower in after-market hours, diverging from broader market gains. No specific news was identified to explain the decline.

20 sie 2026, 22:46 UTC

Agilent Technologies Inc. shares are lower in after-market trading, following a slight decline since Thursday's close amid rising U.S. Treasury yields.

19 sie 2026, 20:03 UTC

News

Agilent Technologies Inc is rising, supported by strength in the Life Sciences Tools & Services sector. The broader market has also shown significant gains since Tuesday.

18 sie 2026, 23:51 UTC

Agilent Technologies Inc shares declined in after-market hours amid broader market concerns over rising bond yields and inflation linked to geopolitical tensions.

12 sie 2026, 19:26 UTC

Agilent Technologies Inc shares are lower today, continuing a decline since Tuesday's close. The stock reached a session low earlier in the session.

11 sie 2026, 21:02 UTC

Agilent Technologies Inc. shares are lower in after-market trading, continuing a decline since Tuesday's close despite being above the 20-day moving average.

7 sie 2026, 20:03 UTC

Agilent Technologies Inc shares are higher today, supported by strong demand and momentum above the 20-day moving average. No specific news was identified.

6 sie 2026, 20:07 UTC

Agilent Technologies Inc shares are higher today amid mixed economic data, including increased labor productivity and rising unit labor costs. No specific company news was identified.

5 sie 2026, 19:52 UTC

Correlated Moves

Agilent Technologies Inc is rising, driven by gains in the Life Sciences Tools & Services sector and a notable increase in Charles River Laboratories shares.

4 sie 2026, 21:03 UTC

Agilent Technologies shares declined after hours, reversing an initial uptick. No specific news was identified to explain the movement.

3 sie 2026, 19:26 UTC

Correlated Moves

Agilent Technologies Inc shares are rising, supported by a gain in the VanEck Morningstar Wide Moat ETF and positive trends in major indices.

31 lip 2026, 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30 lip 2026, 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29 lip 2026, 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28 lip 2026, 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27 lip 2026, 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24 lip 2026, 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23 lip 2026, 20:03 UTC

Correlated Moves
News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22 lip 2026, 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21 lip 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20 lip 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Peer Comparison

Price change

Agilent Technologies Inc Forecast

Price Target

By TipRanks

16.39% upside

12 Months Forecast

Average 176.21 USD  16.39%

High 190 USD

Low 150 USD

Based on 14 Wall Street analysts offering 12 month price targets forAgilent Technologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

12

Buy

2

Hold

0

Sell

Sentiment

By Acuity

305 / 340 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
help-icon Live chat